Search by Drug Name or NDC

    NDC 00067-8127-08 Theraflu ExpressMax 650; 20; 10 mg/30mL; mg/30mL; mg/30mL Details

    Theraflu ExpressMax 650; 20; 10 mg/30mL; mg/30mL; mg/30mL

    Theraflu ExpressMax is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00067-8127
    Product ID 0067-8127_83aacea7-68a1-494d-b36c-6d72a1e61584
    Associated GPIs 43996903400910
    GCN Sequence Number 061337
    GCN Sequence Number Description d-methorphan/PE/acetaminophen LIQUID 5-325MG/15 ORAL
    HIC3 B4M
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-ANALGESIC COMB
    GCN 97129
    HICL Sequence Number 008885
    HICL Sequence Number Description DEXTROMETHORPHAN HBR/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Theraflu ExpressMax
    Proprietary Name Suffix Daytime Severe Cold and Cough
    Non-Proprietary Name Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 650; 20; 10
    Active Ingredient Units mg/30mL; mg/30mL; mg/30mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-8127-08 (00067812708)

    NDC Package Code 0067-8127-08
    Billing NDC 00067812708
    Package 245.5 mL in 1 BOTTLE (0067-8127-08)
    Marketing Start Date 2015-07-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL ff48b55a-0d32-47d6-941d-d99c7cf52f94 Details

    Revised: 4/2022